Ongoing studies by the German CLL study group (GCLLSG)

At the 20th Congress of the European Hematology Association (EHA), Barbara Eichhorst, MD, of the University of Cologne, Cologne, Germany, discusses ongoing clinical studies by the German CLL study group (GCLLSG) that are investigating new therapies for patients with chronic lymphocytic leukaemia (CLL), including obinutuzumab plus chlorambucil, a watch-and-wait strategy and a four-arm study comparing standard chemotherapy versus non-chemotherapy containing regimens.

Year of Production:
Running Time:
Color/Sound:

2015
02:38
Color/Sound

Comments are closed.